What British American Tobacco Holders Bought Into

If British American Tobacco was only on your watchlist rather than in your portfolio, the return may sting a little. Holding British American Tobacco over the past year would have returned 23.0%, including dividends. That result landed despite headlines about regulation, ESG pressure and disagreement between bullish and bearish analyst fair values. If you rewound to October 2025, what signal in the debate over smokeless growth and digital transformation could have given you confidence that those cash flows would hold up?

Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.

If the move has made British American Tobacco harder to judge, start where the gap is still open and scan 7 high quality undervalued stocks.

The Argument You Would Have Been Weighing On British American Tobacco

The shares cost £38.22 at the start of the period, and British American Tobacco sat between two very different stories about where those earnings streams might head next.

On the bullish side, the Fair Value was £42.67, based on assumptions that revenue would grow 2.4% a year and that smokeless products plus digital transformation could support a 30.3% profit margin within three years.

The bearish view put Fair Value at £26.5, focusing on the risk that tighter global regulation, shifting attitudes to nicotine and ESG-driven selling would hold back volumes and compress the valuation placed on those future cash flows.

What The Results Changed For British American Tobacco

The most telling development was British American Tobacco’s Fit2Win restructuring, which targeted 5,500 job cuts and £600m of annual savings, directly echoing the focus on cost efficiency and digital transformation. Reported numbers suggested a different picture. Revenue in H1 2026 was £12,235m against £12,069m in H1 2025, while net income and net margin both fell. The evidence pointed in both directions.

The decision in 2025 largely depended on whether efficiency plans would protect profitability. When you see a cost program announced, check later filings for the net margin line to see if those savings are reflected in earnings.

What British American Tobacco’s Price Implies Today

British American Tobacco now trades at £44.57, and the selected Narrative’s Fair Value sits above that level based on its own framework rather than any proven fact.

The Narrative leans on reduced risk products, AI powered efficiency and buybacks to support that higher figure. A buyer today would need confidence that smokeless margins can keep rising as combustible volumes mature.

"Digital transformation, operational streamlining, and targeted cost savings programs (e.g., Fit2Win, global supply chain efficiencies) are releasing capital for reinvestment in high-return growth opportunities and innovation, protecting operating margins and supporting future free cash flow growth."

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all

Find Your Own Contrarian Opportunity

By the time a rally makes headlines, you are reading about returns someone else has already earned. Why not go straight to the source and look for your own contrarian opportunity? These three companies trade below our estimated value.

• Company 1 - 19% below our estimate - expands supplement offerings while supporting distributor-led entries into new regions.
• Company 2 - 34% below our estimate - grows fee income by structuring capital raises for targeted investment funds.
• Company 3 - 28% below our estimate - attracts platform assets as advisers consolidate clients onto integrated technology solutions.

Three companies from the same screener. Open every one of the 9 solid balance sheet companies →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com